Latest filing published 03 Sept 2026 for Apogee Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by William A. Jones Jr. span 3 companies, the busiest being Biohaven Pharmaceutical Holding Co Ltd., Apogee Therapeutics, Inc. and NewAmsterdam Pharma Co N.V. The record holds 5 filings, for trades running from 25 November 2021 to 3 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 3 September 2026, reports a transaction in Apogee Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations